Bone cancer, from the lab to the clinic
Links shared publicly online about this topic.
- 234total visits
Bone cancer, from the lab to the clinic
View full resource at medicalxpress.com
Tags: Cancer, Bone Cancer, Osteosarcoma, Bone, Lab Test, Healthcare, Genes, Children's Health
Most Recently Shared on June 8, 2011 at 9:35 am By:
Bone cancer, from the lab to the clinic http://bit.ly/jc6gdK
Also Shared By:
Bone Heath Improved By Everolimus Plus Exemestane In Post-Menopausal Women With Advanced Breast Cancer
medicalnewstoday.com — “Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantl” View full resource at medicalnewstoday.com
Most Recently Shared on March 27, 2012 at 7:05 am By:
Bone Heath Improved By Everolimus Plus Exemestane In Post-Menopausal Women With Advanced Breast Cancer: Results ... http://t.co/UZsEDAbO
Combination of everolimus and exemestane reduces spread of cancer in the bone
news-medical.net — “Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone.” View full resource at news-medical.net
Most Recently Shared on March 23, 2012 at 3:48 pm By:
Combination of everolimus and exemestane reduces spread of cancer in the bone: Results from a phase III clinical... http://t.co/U7ANfKPL
Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer
medicalxpress.com — “Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chances of cancer spreading (metastasising) in the bone.” View full resource at medicalxpress.com
Most Recently Shared on March 23, 2012 at 1:16 pm By:
PhysOrg Health News Health News
Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer http://t.co/iI46fpTu
Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer
eurekalert.org — “Latest results from the BOLERO-2 international trial, presented at the 8th European Breast Cancer Conference in Vienna, show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chance of cancer spreading in the bone in post-menopausal women with breast cancer. The researchers believe that their findings will change clinical practice.” View full resource at eurekalert.org
Most Recently Shared on March 23, 2012 at 12:41 pm By:
Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer: (ECCO-the ... http://t.co/0NtsGjmO
Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer
eurekalert.org — “Latest results from the BOLERO-2 international trial, presented at the 8th European Breast Cancer Conference in Vienna, show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces the chance of cancer spreading in the bone in post-menopausal women with breast cancer. The researchers believe that their findings will change clinical practice.” View full resource at eurekalert.org
Most Recently Shared on March 23, 2012 at 9:43 am By:
Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer: Latest res... http://t.co/LHNCxJ2g
Oncology Medical Article | Denosumab Dose Selection for Patients with Bone Metastases from Solid Tumors
mdlinx.com — “Oncology Medical Article: Denosumab Dose Selection for Patients with Bone Metastases from Solid Tumors” View full resource at mdlinx.com
Most Recently Shared on March 14, 2012 at 1:48 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Denosumab Dose Selection for Patients with Bone Metastases from Solid Tumors: Clinical Cancer Research http://t.co/zVkdeour #oncology
One Woman's Experience As A Clinical Trial 'Lab Rat' : NPR
npr.org — “A year after recovering from malignant melanoma, Salon.com writer Mary Elizabeth Williams found out it had returned in the form of metastatic, Stage 4 cancer. In October 2011, she started a clinical trial for a new melanoma drug. Halfway through the trial, she discusses her "life as a lab rat."” View full resource at npr.org
Most Recently Shared on February 9, 2012 at 7:30 pm By:
NAMI Massachusetts Health Organization
One Woman's Experience As A Clinical Trial 'Lab Rat' http://t.co/WOdKOhKP Have you participated in a clinical trial?
"I have your results" - Cancer - Salon.com
salon.com — “Three months into a draining clinical trial, the doctor called with news. Was it working -- or not?” View full resource at salon.com
Most Recently Shared on February 1, 2012 at 3:36 am By:
David Basanta PhD and Doctor
RT @kerrylauerman: Another terrific post from our champion lab rat, the incandescent @embeedub http://t.co/3WkfJhVM
Medical News: CIBD: Puzzling Fracture Risk in Young Breast Ca Patients - in Meeting Coverage, CIBD from MedPage Today
medpagetoday.com — “CHICAGO -- Premenopausal breast cancer patients had a 60% greater incidence of fractures than the rate observed in clinical trials, and most of the fractures occurred in women with normal bone density” View full resource at medpagetoday.com
Most Recently Shared on December 2, 2011 at 12:35 am By:
CIBD: Puzzling Fracture Risk in Young Breast Ca Patients (CME/CE) http://t.co/WER0KzOc
Vitamin D: Who Should Take a Supplement | Vitality - Yahoo! Shine
shine.yahoo.com — “Read 'Vitamin D: Who Should Take a Supplement' from our blog Vitality on Yahoo! Shine. Vitamin D provides a wide range of health benefits. It is effective in preventing rickets and treating other bone diseases such as osteoporosis. According to the Mayo Clinic, getting enough vitamin D may prevent high blood pressure and protect against certain types of cancer. It may also promote weight loss for women. A growing body of research links heart health to sufficient vitamin D. ...” View full resource at shine.yahoo.com
Most Recently Shared on December 1, 2011 at 12:07 pm By:
Dr. Bruce Guillory Doctor, CAM, and Chiropractor
Vitamin D: Who Should Take a Supplement | Vitality - Yahoo! Shine http://t.co/z88aty2z via @addthis
Medical News: Spine Surgeons React to BMP-2 Cancer Data - in Orthopedics, Orthopedics from MedPage Today
medpagetoday.com — “CHICAGO -- Spine surgery patients who got a bone growth stimulating agent as part of a clinical trial were three to five times more likely to develop cancer two to three years after being implanted wi” View full resource at medpagetoday.com
Most Recently Shared on November 5, 2011 at 5:00 pm By:
Patricia Grace Eldercare Expert
Spine Surgeons React to BMP-2 Cancer Data: CHICAGO (MedPage Today) -- Spine surgery patients who got a bone grow... http://t.co/htFjUrUF
A Drug's Journey from Lab to Patient - Dana-Farber Cancer Institute
dana-farber.org — “Dana-Farber’s Early Drug Development Center gives patients access to experimental drug combinations through phase I clinical trials for cancer.” View full resource at dana-farber.org
Most Recently Shared on November 4, 2011 at 1:44 pm By:
The Jimmy Fund Health Organization
RT @danafarber: How a #cancer drug progresses from lab to patient in phase I clinical trials http://t.co/rWH10uS3
Medical News: ASCO: Bone Effects Fuel Optimism for Prostate Ca Drug - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Two-thirds of men with castration-resistant prostate cancer (CRPC) had clinical benefit when treated with an investigational multitargeted tyrosine kinase inhibitor, data from a randomized” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 7:33 pm By:
Roger D. Jones, PhD Health Social Media, PhD, Doctor, and Health Executive
Medical News: ASCO: Bone Effects Fuel Optimism for Prostate Ca Drug - http://t.co/GjoUOns from @medpagetoday #health #medicine
Introducing Dr. Stephen Noga, a Leading Medical Expert
blog.healthtap.com — “HealthTap is pleased to feature Dr. Stephen Noga, a Leading Medical Expert. Dr. Noga has an impressive and extensive academic career. He received his PhD in Experimental Pathology from the University of Florida and his MD from John Hopkins University. While completing his MD, he simultaneously did Post-Doctoral Research and served a Fellowship in Oncology in the Bone Marrow Transplant unit. Dr. Noga then completed his Residency in Internal Medicine and was a Senior Clinical Fellow of Oncology at” View full resource at blog.healthtap.com
Most Recently Shared on August 16, 2011 at 9:35 pm By:
Welcome Dr. Stephen Noga to our Medical Expert Network. Dr. Noga is a specialists in oncology and #cancer research http://t.co/XzIvQdc
News From The Journal Of Clinical Investigation: Aug. 15, 2011
medicalnewstoday.com — “ONCOLOGY: How a virus causes skin cancer Merkel cell carcinoma (MCC) is a rare but aggressive form of skin cancer. It was recently found that most cases of MCC are caused by Merk” View full resource at medicalnewstoday.com
Most Recently Shared on August 16, 2011 at 9:06 am By:
News From The Journal Of Clinical Investigation: Aug. 15, 2011 http://mnt.to/3YXN #skincancer #melanoma
Advertisement
PhysOrg Health News
@physorg_health
Everolimus plus exemestane improves bone health in post-menopausal women with advanced breast cancer http://t.co/iI46fpTu
1 year ago...